AU2734595A - Factor interacting with nuclear proteins - Google Patents

Factor interacting with nuclear proteins

Info

Publication number: AU2734595A
Authority: AU; Australia
Prior art keywords: nuclear proteins; factor interacting; interacting; factor; nuclear
Prior art date: 1994-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU27345/95A

Inventor

Patrick Matthias

Michel Strubin

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-24

Filing date

1995-05-15

Publication date

1995-12-18

1995-05-15 Application filed by Novartis AG filed Critical Novartis AG

1995-12-18 Publication of AU2734595A publication Critical patent/AU2734595A/en

1998-02-26 Assigned to NOVARTIS AG reassignment NOVARTIS AG Amend patent request/document other than specification (104) Assignors: CIBA-GEIGY AG

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Wood Science & Technology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU27345/95A 1994-05-24 1995-05-15 Factor interacting with nuclear proteins Abandoned AU2734595A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP94810299		1994-05-24
EP94810299		1994-05-24
PCT/EP1995/001834 WO1995032284A1 (en)	1994-05-24	1995-05-15	Factor interacting with nuclear proteins

Publications (1)

Publication Number	Publication Date
AU2734595A true AU2734595A (en)	1995-12-18

Family

ID=8218256

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU27345/95A Abandoned AU2734595A (en)	1994-05-24	1995-05-15	Factor interacting with nuclear proteins

Country Status (7)

Country	Link
EP (1)	EP0763109A1 (en)
JP (1)	JPH10500311A (en)
AU (1)	AU2734595A (en)
CA (1)	CA2188423A1 (en)
FI (1)	FI964606A0 (en)
NO (1)	NO964981L (en)
WO (1)	WO1995032284A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4596597A (en) *	1996-09-27	1998-04-17	Icos Corporation	Method to identify compounds for disrupting protein/protein interactions
WO2000078951A1 (en) *	1999-06-18	2000-12-28	Ariad Gene Therapeutics, Inc.	Chimeric oca-b transcription factors
CN1322746A (en) *	2000-05-09	2001-11-21	上海博德基因开发有限公司	New polypeptide human actamer-binding protein 48 and its encoding polynucleotides
GB0120441D0 (en) *	2001-08-22	2001-10-17	Novartis Forschungsstiftung	Model of autoimmune disease and methods for identifying anti autoimmune disease disorders
EP1589030A1 (en) *	2004-04-14	2005-10-26	Friedrich-Alexander-Universität Erlangen-Nürnberg	Bob-1 specific T cells and methods to use
CN100340674C (en) *	2005-04-28	2007-10-03	中国人民解放军总医院	Deaf-related gene mutation and its detecting method
JP2008072939A (en) *	2006-09-21	2008-04-03	Fujifilm Corp	Method for detecting and inhibiting multiple myeloma

1995
- 1995-05-15 CA CA002188423A patent/CA2188423A1/en not_active Abandoned
- 1995-05-15 EP EP95922452A patent/EP0763109A1/en not_active Withdrawn
- 1995-05-15 FI FI964606A patent/FI964606A0/en not_active Application Discontinuation
- 1995-05-15 AU AU27345/95A patent/AU2734595A/en not_active Abandoned
- 1995-05-15 WO PCT/EP1995/001834 patent/WO1995032284A1/en not_active Application Discontinuation
- 1995-05-15 JP JP7530029A patent/JPH10500311A/en active Pending
1996
- 1996-11-22 NO NO964981A patent/NO964981L/en unknown

Also Published As

Publication number	Publication date
JPH10500311A (en)	1998-01-13
NO964981D0 (en)	1996-11-22
EP0763109A1 (en)	1997-03-19
WO1995032284A1 (en)	1995-11-30
FI964606L (en)	1996-11-18
NO964981L (en)	1996-11-22
FI964606A7 (en)	1996-11-18
CA2188423A1 (en)	1995-11-30
FI964606A0 (en)	1996-11-18

Publication	Publication Date	Title
AU1475795A (en)	1995-09-21	Containment flap construction
AU6722296A (en)	1997-03-19	Seed-blanket reactors
AU3811495A (en)	1996-05-31	Antibodies
AU4370596A (en)	1996-06-26	Novel hedgehog-derived polypeptides
AU2832295A (en)	1996-02-22	Cytoanalyzer
AU5979994A (en)	1995-08-21	Framed construction
AUPM411994A0 (en)	1994-03-24	Epitopes
AU2705395A (en)	1996-01-05	Fas associated proteins
AU3397195A (en)	1996-03-27	Construction elements
AU2837895A (en)	1996-06-27	Thiazine- or thiazepine-derivatives
AU2131195A (en)	1995-10-23	Prophenins - antibiotic peptides
AU2308295A (en)	1995-11-16	Heterocyclylbenzonitriles
AU3994095A (en)	1996-06-19	Thrombocytotic factor
GB9314802D0 (en)	1993-08-25	Modified proteins
AU1963395A (en)	1995-10-17	Boom-structure
AU2734595A (en)	1995-12-18	Factor interacting with nuclear proteins
AU3528795A (en)	1996-04-09	Copolyesters
IL115317A0 (en)	1995-12-31	Proteins
AUPM489194A0 (en)	1994-04-28	Peptides
AU2803595A (en)	1996-02-09	Immunodominant polypeptides
AU2411395A (en)	1995-12-05	Hydrocopter
AU1603595A (en)	1995-08-21	Meso-azanoradamantanes
AU6595998A (en)	1998-07-02	Containment flap construction
AU2002300912A1 (en)	2003-02-20	Modified Factor VII
AU1787395A (en)	1995-07-27	Bridge structure